The EXPLORE MG Registry for Myasthenia Gravis

Yale University

Status: Enrolling

Conditions: Myasthenia Gravis

Treatments: Other: Blood Sample Draw

Study type: Observational

Funder types: Other

Identifiers

NCT03792659

1602017284

Details and patient eligibility

About

The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.

Full description

This registry will allow for the research of several mechanisms of Myasthenia Gravis (MG) by studying peripheral blood, stool, disease status and course, and treatment of subjects with MG. The EXPLORE-MG Registry focuses on varied aspects of MG such as disease management, health care utilization, health costs, disease characteristics, and diagnostic tools. As such, it will aid in a broader understanding of MG, while providing a registry from which questions about the disease may be better answered.

Enrollment: 800 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data.

Exclusion criteria

• Failure to meet the Inclusion Criteria.

Trial design

800 participants in 1 patient group

Neurological Outpatients

Description:

Participants in this group will be recruited from the outpatient clinical population at the Yale University Department of Neurology. Treating physicians will make the initial determination of patients' potential eligibility to participate in the study.

Treatment:

Other: Blood Sample Draw